IRIS
CIRIONI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.751
EU - Europa 6.016
AS - Asia 4.663
SA - Sud America 1.104
AF - Africa 287
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.586
SG - Singapore 1.855
UA - Ucraina 1.199
BR - Brasile 922
CN - Cina 912
RU - Federazione Russa 721
IE - Irlanda 677
IT - Italia 676
SE - Svezia 661
DE - Germania 660
TR - Turchia 563
HK - Hong Kong 450
DK - Danimarca 433
VN - Vietnam 343
FI - Finlandia 317
KR - Corea 241
FR - Francia 237
GB - Regno Unito 224
CI - Costa d'Avorio 195
CA - Canada 78
AR - Argentina 74
IN - India 68
MX - Messico 65
BD - Bangladesh 39
NL - Olanda 39
JP - Giappone 37
EC - Ecuador 36
PL - Polonia 36
ZA - Sudafrica 35
AT - Austria 32
ID - Indonesia 31
IR - Iran 27
BE - Belgio 26
MA - Marocco 25
ES - Italia 20
CO - Colombia 19
PY - Paraguay 19
PK - Pakistan 16
IQ - Iraq 15
RO - Romania 13
UZ - Uzbekistan 12
EG - Egitto 11
LT - Lituania 10
PE - Perù 10
CL - Cile 9
EU - Europa 8
VE - Venezuela 8
AU - Australia 7
BG - Bulgaria 7
NP - Nepal 7
DO - Repubblica Dominicana 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CH - Svizzera 5
DZ - Algeria 5
TH - Thailandia 5
HR - Croazia 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
OM - Oman 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CY - Cipro 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
UY - Uruguay 3
A1 - Anonimo 2
AL - Albania 2
BB - Barbados 2
CM - Camerun 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KI - Kiribati 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
Totale 23.833
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.207
Ashburn 1.116
Singapore 1.080
Chandler 1.054
Dallas 878
Fairfield 832
Dublin 668
Boardman 616
Wilmington 489
Hong Kong 442
Woodbridge 401
New York 355
Seattle 322
Houston 313
Ann Arbor 279
Des Moines 264
Lawrence 254
Princeton 254
Cambridge 250
San Mateo 247
Beijing 244
Moscow 209
Abidjan 195
Los Angeles 172
Hefei 168
Ho Chi Minh City 135
Munich 125
San Diego 119
Turin 111
Centro 91
Buffalo 86
São Paulo 79
The Dalles 71
Turku 64
Hanoi 62
Redmond 58
London 49
Chicago 41
Guangzhou 37
Shanghai 37
Santa Clara 35
Ancona 34
Columbus 31
Tokyo 31
Montreal 30
Warsaw 29
Washington 29
Helsinki 28
Izmir 28
Norwalk 28
Rio de Janeiro 28
Brussels 25
Mexico City 23
Nuremberg 23
Wuhan 23
Falls Church 22
Marche 22
Johannesburg 21
Rome 21
Atlanta 20
Brasília 20
Denver 20
Porto 20
Belo Horizonte 19
Brooklyn 18
Da Nang 18
Milan 18
Chennai 16
Manchester 16
Poplar 16
Salt Lake City 16
Vienna 16
Boston 15
Curitiba 15
Kilburn 15
Ottawa 15
Phoenix 15
San Francisco 15
Stockholm 15
Cingoli 14
Guayaquil 14
Jiaxing 14
Orem 14
Pune 14
Guarulhos 13
Jakarta 12
Tashkent 12
Wuxi 12
Campinas 11
Dhaka 11
Seoul 11
Biên Hòa 10
Haiphong 10
Pesaro 10
Ankara 9
North Bergen 9
Porto Alegre 9
Urbisaglia 9
Amsterdam 8
Dronten 8
Totale 14.557
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 296
Antimicrobial Resistance: A Challenge for the Future 263
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 233
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 204
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 176
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 175
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 173
Anticryptosporidial activity of paromomycin. 171
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 159
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 156
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 153
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 151
Antimicrobial activity of polycationic peptides 147
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 147
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 144
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 142
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 134
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 132
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 132
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 131
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 130
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 127
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 126
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 126
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 124
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 122
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 121
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 121
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 121
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 120
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 120
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 118
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 118
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 117
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 117
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 116
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 116
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 115
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 115
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 114
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 114
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 114
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 113
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 112
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 111
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 111
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 111
Animal models commonly used to study quorum-sensing inhibitors. 109
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 109
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 109
Review: A safety profile of dalbavancin for onand off-label utilization 109
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 108
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 108
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 108
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 107
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 107
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 106
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 106
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 106
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 106
Epidemiology and microbiology of surgical wound infections. 105
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 105
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 104
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 104
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 103
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 103
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 103
Urinary catheters and biofilm formation 103
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 103
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 103
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 102
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 102
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 102
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 102
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 102
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 101
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 100
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 100
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 100
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 100
Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: Possible options for the treatment of complicated infections 100
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 99
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 99
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 97
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 97
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 97
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 97
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 96
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 96
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 95
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 95
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 95
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 95
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 95
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 95
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 95
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 95
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 95
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 94
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 94
Totale 11.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.103 0 0 0 0 0 233 371 223 365 366 376 169
2021/20222.026 132 443 13 105 33 147 91 117 142 265 131 407
2022/20233.451 341 334 254 246 267 516 7 182 884 18 273 129
2023/20241.976 363 46 133 319 347 415 34 55 22 23 26 193
2024/20254.249 544 333 248 131 156 213 419 169 892 227 417 500
2025/20265.139 676 930 963 1.299 1.091 180 0 0 0 0 0 0
Totale 24.189